Skip to content
Go to home page
Join
  1. Home
  2. News and press releases
  3. Winner of the Innovation Prize

Winner of the Innovation Prize

Photocure won the Norwegian Cancer Society Innovation Prize during the 10th anniversary celebration of Oslo Cancer Cluster Innovation Park.

A woman in a green blazer hands a vibrant bouquet of multicolored flowers to another woman wearing a black shirt and a name tag reading "Kristine Young Heltveiten," who smiles while holding a framed certificate titled “Vekstbedriftens kompetansepris 2023” awarded to "Preceyes B.V." The background features an orange banner with the Oslo Cancer Cluster Innovation Park branding and a potted plant.
Ingrid Stenstadvold Ross, Secretary-General of the Norwegian Cancer Society, presented the innovation award, amounting to NOK 300,000, to Photocure during the anniversary show. Kristine Young-Halvosen, Clinical Development and Medical Science Director, accepted the prize on behalf of Photocure. All photos: Oslo Cancer Cluster/ George Cherry Jjordene

You can watch the entire anniversary show! Follow the link in the story.

Published

Dec 2, 2025

Author

Wenche Gerhardsen

Category
Award

Photocure states that the prize recognizes the company's commitment to advancing cancer diagnostics and improving patient outcomes.

The award, accompanied by a prize of 300,000 NOK, was presented after a rigorous evaluation by a committee appointed by the Norwegian Cancer Society. 

Read about the nomination process and all the nominees.

Woman with curly brown hair in a black blouse standing against an orange backdrop, holding a colorful bouquet of flowers and a black-framed certificate. She wears a blue lanyard with a name tag that reads "Kristine Young-Harverson" and appears to be receiving an award. A person in the foreground holds a microphone towards her as she speaks. The vibrant bouquet includes purple chrysanthemums, light pink statice, peach roses, and greenery. Event or conference setting with professional recognition theme.
Kristine Young-Halvosen, Clinical Development and Medical Science Director, accepted the prize on behalf of Photocure.

The benefit to the patient

Ingrid Stenstadvold Ross, Secretary-General of the Norwegian Cancer Society, presented the innovation award to the bladder cancer company Photocure.

During the award ceremony, Stenstadvoll Ross emphasized how Photocure had established itself as a leading player in Europe and the United States in the field of bladder cancer, bringing products to market and continuing to drive innovation through research and development. The proven benefit to the patient was a key factor in the committee’s decision. 

Immensely proud

“We are immensely proud that our ongoing innovative work in bladder cancer diagnostics has been recognized on such a prominent platform. As advancements in pharmaceutical therapies for bladder cancer – including immune and gene therapies – continue to transform patient care, the need for precise diagnostics becomes even more critical. Photocure remains dedicated to delivering innovative solutions that help select the right treatment for each patient, and monitor for relapse and treatment response, and ultimately, improve outcomes in uro-oncology,” said Anders Neijber, Chief Medical Officer of Photocure, in the company's press release.

Similar articles